Investigators employed artificial intelligence to characterize tissue samples of high-risk NMIBC that were likely to recur or progress after treatment with intravesical bacillus Calmette-Guérin (BCG).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback